HomeALDX • NASDAQ
add
Aldeyra Therapeutics Inc
Previous close
$4.59
Day range
$4.51 - $4.91
Year range
$1.14 - $7.19
Market cap
273.14M USD
Avg Volume
861.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 8.00M | -50.42% |
Net income | -7.69M | 49.13% |
Net profit margin | — | — |
Earnings per share | -0.13 | 48.00% |
EBITDA | -7.94M | 50.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.30M | 3.51% |
Total assets | 77.80M | -33.68% |
Total liabilities | 28.56M | -11.38% |
Total equity | 49.24M | — |
Shares outstanding | 60.16M | — |
Price to book | 5.60 | — |
Return on assets | -24.58% | — |
Return on capital | -29.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.69M | 49.13% |
Cash from operations | -7.02M | 11.96% |
Cash from investing | 25.00M | 375.05% |
Cash from financing | 120.75K | 161.17% |
Net change in cash | 18.10M | 722.04% |
Free cash flow | -3.28M | -164.30% |
About
Founded
2004
Headquarters
Website
Employees
8
